Logo image of LYB

LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

NYSE:LYB - New York Stock Exchange, Inc. - NL0009434992 - Common Stock - Currency: USD

76.96  -0.65 (-0.84%)

After market: 76.96 0 (0%)

Fundamental Rating

5

Overall LYB gets a fundamental rating of 5 out of 10. We evaluated LYB against 85 industry peers in the Chemicals industry. LYB has an average financial health and profitability rating. LYB has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally LYB also has an excellent dividend rating. These ratings could make LYB a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year LYB was profitable.
LYB had a positive operating cash flow in the past year.
LYB had positive earnings in 4 of the past 5 years.
LYB had a positive operating cash flow in 4 of the past 5 years.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

1.2 Ratios

With a decent Return On Assets value of 5.75%, LYB is doing good in the industry, outperforming 79.52% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.61%, LYB belongs to the top of the industry, outperforming 81.93% of the companies in the same industry.
LYB's Return On Invested Capital of 7.86% is fine compared to the rest of the industry. LYB outperforms 77.11% of its industry peers.
LYB had an Average Return On Invested Capital over the past 3 years of 14.60%. This is significantly above the industry average of 6.65%.
The 3 year average ROIC (14.60%) for LYB is well above the current ROIC(7.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.75%
ROE 15.61%
ROIC 7.86%
ROA(3y)10.55%
ROA(5y)9.36%
ROE(3y)31.46%
ROE(5y)30.87%
ROIC(3y)14.6%
ROIC(5y)12.53%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

1.3 Margins

LYB has a Profit Margin of 5.26%. This is in the better half of the industry: LYB outperforms 61.45% of its industry peers.
In the last couple of years the Profit Margin of LYB has declined.
LYB has a Operating Margin (7.46%) which is in line with its industry peers.
LYB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 11.79%, LYB is doing worse than 78.31% of the companies in the same industry.
In the last couple of years the Gross Margin of LYB has declined.
Industry RankSector Rank
OM 7.46%
PM (TTM) 5.26%
GM 11.79%
OM growth 3Y4.04%
OM growth 5Y-8.32%
PM growth 3Y0.06%
PM growth 5Y-15.65%
GM growth 3Y1.51%
GM growth 5Y-5.08%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

5

2. Health

2.1 Basic Checks

LYB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
LYB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.61 indicates that LYB is not a great score, but indicates only limited risk for bankruptcy at the moment.
LYB has a Altman-Z score of 2.61. This is in the better half of the industry: LYB outperforms 74.70% of its industry peers.
LYB has a debt to FCF ratio of 7.09. This is a slightly negative value and a sign of low solvency as LYB would need 7.09 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.09, LYB is in the better half of the industry, outperforming 63.86% of the companies in the same industry.
A Debt/Equity ratio of 0.82 indicates that LYB is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.82, LYB is not doing good in the industry: 60.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 7.09
Altman-Z 2.61
ROIC/WACC1.05
WACC7.51%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.3 Liquidity

LYB has a Current Ratio of 2.13. This indicates that LYB is financially healthy and has no problem in meeting its short term obligations.
LYB has a Current ratio (2.13) which is comparable to the rest of the industry.
LYB has a Quick Ratio of 1.25. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
LYB has a Quick ratio (1.25) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.25
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

1

3. Growth

3.1 Past

The earnings per share for LYB have decreased strongly by -27.27% in the last year.
Measured over the past years, LYB shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.75% on average per year.
EPS 1Y (TTM)-27.27%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.35%

3.2 Future

LYB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.47% yearly.
Based on estimates for the next years, LYB will show a decrease in Revenue. The Revenue will decrease by -4.35% on average per year.
EPS Next Y-3.77%
EPS Next 2Y13.63%
EPS Next 3Y12.74%
EPS Next 5Y12.47%
Revenue Next Year-19.19%
Revenue Next 2Y-8.56%
Revenue Next 3Y-4.6%
Revenue Next 5Y-4.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.02, which indicates a correct valuation of LYB.
LYB's Price/Earnings ratio is rather cheap when compared to the industry. LYB is cheaper than 83.13% of the companies in the same industry.
LYB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
The Price/Forward Earnings ratio is 12.50, which indicates a correct valuation of LYB.
72.29% of the companies in the same industry are more expensive than LYB, based on the Price/Forward Earnings ratio.
LYB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.02
Fwd PE 12.5
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LYB is valued cheaper than 81.93% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LYB indicates a somewhat cheap valuation: LYB is cheaper than 69.88% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.69
EV/EBITDA 7.4
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of LYB may justify a higher PE ratio.
LYB's earnings are expected to grow with 12.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.63%
EPS Next 3Y12.74%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.91%, LYB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.27, LYB pays a better dividend. On top of this LYB pays more dividend than 92.77% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, LYB pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.91%

5.2 History

The dividend of LYB has a limited annual growth rate of 4.19%.
LYB has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)4.19%
Div Incr Years0
Div Non Decr Years0
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

5.3 Sustainability

78.89% of the earnings are spent on dividend by LYB. This is not a sustainable payout ratio.
The dividend of LYB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP78.89%
EPS Next 2Y13.63%
EPS Next 3Y12.74%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B
LYB Dividend Payout.LYB Dividend Payout, showing the Payout Ratio.LYB Dividend Payout.PayoutRetained Earnings

LYONDELLBASELL INDU-CL A

NYSE:LYB (2/21/2025, 8:04:00 PM)

After market: 76.96 0 (0%)

76.96

-0.65 (-0.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-31 2025-01-31/bmo
Earnings (Next)04-24 2025-04-24/bmo
Inst Owners73.27%
Inst Owner Change1.47%
Ins Owners0.15%
Ins Owner Change0.01%
Market Cap24.94B
Analysts67.14
Price Target87.43 (13.6%)
Short Float %1.97%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield 6.91%
Yearly Dividend4.95
Dividend Growth(5Y)4.19%
DP78.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.32%
Min EPS beat(2)-5.89%
Max EPS beat(2)-0.76%
EPS beat(4)2
Avg EPS beat(4)2.29%
Min EPS beat(4)-5.89%
Max EPS beat(4)10.97%
EPS beat(8)6
Avg EPS beat(8)10.28%
EPS beat(12)8
Avg EPS beat(12)5.3%
EPS beat(16)11
Avg EPS beat(16)8.96%
Revenue beat(2)1
Avg Revenue beat(2)-1.75%
Min Revenue beat(2)-3.6%
Max Revenue beat(2)0.09%
Revenue beat(4)2
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-3.6%
Max Revenue beat(4)0.99%
Revenue beat(8)3
Avg Revenue beat(8)-1.93%
Revenue beat(12)6
Avg Revenue beat(12)-0.08%
Revenue beat(16)9
Avg Revenue beat(16)1.48%
PT rev (1m)-4.26%
PT rev (3m)-15.18%
EPS NQ rev (1m)-43.9%
EPS NQ rev (3m)-44.29%
EPS NY rev (1m)-4.01%
EPS NY rev (3m)-7.8%
Revenue NQ rev (1m)-4.39%
Revenue NQ rev (3m)-5.19%
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-0.97%
Valuation
Industry RankSector Rank
PE 12.02
Fwd PE 12.5
P/S 0.61
P/FCF 15.69
P/OCF 7.32
P/B 1.82
P/tB 2.17
EV/EBITDA 7.4
EPS(TTM)6.4
EY8.32%
EPS(NY)6.16
Fwd EY8%
FCF(TTM)4.9
FCFY6.37%
OCF(TTM)10.52
OCFY13.67%
SpS125.72
BVpS42.33
TBVpS35.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.75%
ROE 15.61%
ROCE 9.71%
ROIC 7.86%
ROICexc 8.57%
ROICexgc 9.3%
OM 7.46%
PM (TTM) 5.26%
GM 11.79%
FCFM 3.9%
ROA(3y)10.55%
ROA(5y)9.36%
ROE(3y)31.46%
ROE(5y)30.87%
ROIC(3y)14.6%
ROIC(5y)12.53%
ROICexc(3y)15.73%
ROICexc(5y)13.41%
ROICexgc(3y)17.27%
ROICexgc(5y)14.81%
ROCE(3y)18.16%
ROCE(5y)15.62%
ROICexcg growth 3Y20.37%
ROICexcg growth 5Y-11.2%
ROICexc growth 3Y20.81%
ROICexc growth 5Y-10.44%
OM growth 3Y4.04%
OM growth 5Y-8.32%
PM growth 3Y0.06%
PM growth 5Y-15.65%
GM growth 3Y1.51%
GM growth 5Y-5.08%
F-Score5
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 7.09
Debt/EBITDA 2.47
Cap/Depr 120.23%
Cap/Sales 4.47%
Interest Coverage 250
Cash Conversion 74.9%
Profit Quality 74.22%
Current Ratio 2.13
Quick Ratio 1.25
Altman-Z 2.61
F-Score5
WACC7.51%
ROIC/WACC1.05
Cap/Depr(3y)129.87%
Cap/Depr(5y)147.1%
Cap/Sales(3y)3.9%
Cap/Sales(5y)5.3%
Profit Quality(3y)124.36%
Profit Quality(5y)108.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-27.27%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.04%
EPS Next Y-3.77%
EPS Next 2Y13.63%
EPS Next 3Y12.74%
EPS Next 5Y12.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.35%
Revenue Next Year-19.19%
Revenue Next 2Y-8.56%
Revenue Next 3Y-4.6%
Revenue Next 5Y-4.35%
EBIT growth 1Y-13.28%
EBIT growth 3Y18.59%
EBIT growth 5Y-7.35%
EBIT Next Year17.01%
EBIT Next 3Y10.89%
EBIT Next 5Y10.96%
FCF growth 1Y-71.12%
FCF growth 3Y32.78%
FCF growth 5Y0.27%
OCF growth 1Y-55.12%
OCF growth 3Y13.23%
OCF growth 5Y-2.01%